Literature DB >> 19299906

Evaluation of posterior pole with echography and optical coherence tomography in patients with Behçet's disease.

Gennarfrancesco Iaccarino1, Gilda Cennamo, Raimondo Forte, Giovanni Cennamo.   

Abstract

BACKGROUND: In Behçet's disease posterior segment involvement is very frequent (about 80%). Macular edema is the most commonly observed complication and is related to reduction of visual acuity. The purpose of the study was to evaluate choroidal involvement during posterior vasculitis due to Behçet's disease.
METHODS: Thirty eyes (15 patients) presenting with posterior vasculitis due to Behçet's disease were studied. All patients had been evaluated with optical coherence tomography (Stratus OCT, Zeiss) to evaluate the retinal thickness (RT) and with standardized 8-MHz A scan echography to determine the retinochoroidal thickness (RCT). Echographic evaluation with 10- and 20-MHz probes was performed in all cases.
RESULTS: In 7 eyes (23.3%), both RT and RCT were normal. In 5 eyes (16.6%), they were both increased. In the other 18 eyes (60%), the RCT was increased while the RT was normal, thus indicating a thickening of the choroid alone. No significant correlation was found between choroidal thickness and the presence of vitreal abnormalities. Neither increases in RT nor those in RCT were significantly related to visual acuity. No correlation was found between RT or RCT and pharmacological treatment.
CONCLUSION: Choroidal inflammation could often play a primary etiological role during posterior vasculitis in Behçet's disease. Echographic detection of choroidal thickening in patients with Behçet's disease not presenting with retinal alterations or visual symptoms could represent a useful way to detect an early inflammation, in order to start a proper therapy and to influence the final visual prognosis. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19299906     DOI: 10.1159/000209274

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  7 in total

Review 1.  Optical coherence tomography imaging in uveitis.

Authors:  Sumru Onal; Ilknur Tugal-Tutkun; Piergiorgio Neri; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-07-09       Impact factor: 2.031

2.  Evaluation of the Macular, Peripapillary Nerve Fiber Layer and Choroid Thickness Changes in Behçet's Disease with Spectral-Domain OCT.

Authors:  Mustafa Ataş; Isa Yuvacı; Süleyman Demircan; Emel Güler; Orhan Altunel; Emine Pangal; Altan Göktaş; Serap Sütbeyaz; Gökmen Zararsız
Journal:  J Ophthalmol       Date:  2014-04-24       Impact factor: 1.909

Review 3.  Examining the choroid in ocular inflammation: a focus on enhanced depth imaging.

Authors:  Abeir Baltmr; Sue Lightman; Oren Tomkins-Netzer
Journal:  J Ophthalmol       Date:  2014-06-16       Impact factor: 1.909

4.  Choroidal thickness in non-ocular Behçet's disease - A spectral-domain OCT study.

Authors:  Aman Mittal; Swetha Bindu Velaga; Khalil Ghasemi Falavarjani; Muneeswar G Nittala; Srinivas R Sadda
Journal:  J Curr Ophthalmol       Date:  2017-06-26

5.  Choroidal Thickness Indicates Subclinical Ocular and Systemic Inflammation in Eyes with Behçet Disease without Active Inflammation.

Authors:  Yoo Ri Chung; Eun Hyung Cho; Seran Jang; Seung Yeop Lee; Eun So Lee; Kihwang Lee
Journal:  Korean J Ophthalmol       Date:  2018-08

6.  Increased Choroidal Thickness in Keratoconus Patients: Perspectives in the Disease Pathophysiology.

Authors:  João Pinheiro-Costa; João Viana Pinto; Sara Perestrelo; João Nuno Beato; Luís Torrão; Elisete Brandão; Ângela Carneiro; Maria Dulce Madeira; Fernando Falcão-Reis
Journal:  J Ophthalmol       Date:  2019-12-03       Impact factor: 1.909

7.  Choroidal assessment in idiopathic panuveitis using optical coherence tomography.

Authors:  Michael Karampelas; Dawn A Sim; Pearse A Keane; Javier Zarranz-Ventura; Praveen J Patel; Adnan Tufail; Mark Westcott; Richard Lee; Carlos E Pavesio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-28       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.